Drug General Information
Drug ID	D0WJ1N
Drug Name	SRI-63-675
Synonyms	109516-82-7; SDZ-63-675; SRI-63-675
Drug Type	Small molecular drug
Indication	Unspecified		Investigative	[1560117]
Structure		Download 2D MOL
Formula	C38H63N2O7P
PubChem Compound ID	122013
Target and Pathway
Target(s)	Platelet-activating factor receptor	Target Info	Modulator
KEGG Pathway	Calcium signaling pathway
	Neuroactive ligand-receptor interaction
	Staphylococcus aureus infection
NetPath Pathway	IL5 Signaling Pathway
	Leptin Signaling Pathway
Reactome	Class A/1 (Rhodopsin-like receptors)
	G alpha (q) signalling events
	Interferon gamma signaling
WikiPathways	GPCRs, Class A Rhodopsin-like
	Gastrin-CREB signalling pathway via PKC and MAPK
	Small Ligand GPCRs
	Interferon gamma signaling
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 1560117	The effect of SRI 63-675, a competitive platelet-activating factor receptor-antagonist, in the generalized Shwartzman reaction.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.